{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-018778","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2022-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.626857+00:00","generated_at":"2026-06-21T02:27:00.425366+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Fortress Biotech Appoints Lucy Lu, M.D. to Board of Directors","bullets":["Lucy Lu, M.D. appointed to Fortress Biotech Board effective December 14, 2022.","Dr. Lu previously served as Fortress CFO (2012-2017) and CEO of subsidiary Avenue Therapeutics.","She brings over 20 years of biotech finance and drug development experience including roles at Citigroup.","Standard-form indemnification agreement entered with Dr. Lu, consistent with other directors' terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-018778","json":"https://secwatch.observer/filing/0001558370-22-018778.json","markdown":"https://secwatch.observer/filing/0001558370-22-018778.md","text":"https://secwatch.observer/filing/0001558370-22-018778.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000155837022018778/0001558370-22-018778-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000155837022018778/fbio-20221214x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T02:27:00.425366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c7606eb7e4","claim":"Lucy Lu, M.D. was elected as Director at Fortress Biotech, Inc..","evidence_excerpt":"On December 14, 2022, the Board of Directors (the “Board”) of the “Company elected Lucy Lu, M.D. as a new member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429260/000155837022018778/0001558370-22-018778-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}